05:32 PM EDT, 03/27/2025 (MT Newswires) -- TransCode Therapeutics ( RNAZ ) started dosing the first patient in the fourth cohort of its phase 1 cancer treatment trial. Two more patients in the cohort are set to receive the TTX-MC138 to inhibit microRNA-10b, a microRNA critical to the emergence and progression of metastatic cancer, the company said Thursday in a...

The Sei Foundation, the nonprofit development organization behind the layer-1 blockchain Sei (SEI), is exploring the acquisition of bankrupt personal genomics company 23andMe and putting the genetic data of 15 million users on blockchain rails. The foundation announced the initiative in an X post on Thursday, calling the plan its boldest DeSci bet yet — referring to the decentralized science...

The Sei Foundation, the nonprofit development organization behind the layer-1 blockchain Sei (SEI), is exploring the acquisition of bankrupt personal genomics company 23andMe and putting the genetic data of 15 million users on blockchain rails. The foundation announced the initiative in an X post on Thursday, calling the plan its boldest DeSci bet yet — referring to the decentralized science...

NEW YORK, March 27 (Reuters) - Sabre is exploring a sale of its hospitality software unit SynXis, in a deal that could be worth more than $1 billion and help the travel technology provider reduce its debt, according to people familiar with the matter. The Southlake, Texas-based firm is working with investment bank Evercore ( EVR ) to gauge interest...